The purpose of this activity is to increase clinician awareness on AUC mandates to mitigate unnecessary costs while providing appropriate care within a multidisciplinary team. This activity will feature a review of AUCs in relation to the reimbursement implications as well as expert guidance on available agents for rMPI and recommendations on when to order PET and SPECT scans.

In this program, Dr. Auwaerter discusses the basics of our understanding of COVID-19.

In this Point-of-Care101 (POC101) educational program, a renowned expert in COPD will review best practices in evaluating and managing patients with moderate to very severe COPD, particularly within the present COVID-19 landscape

Dry eye disease (DED) is a common condition in the general public, with particular prevalence among patients who wear contact lenses and those seeking treatment for cataracts.

Identify risk factors for recurrent Clostridioides difficile infection (CDI) in patients undergoing hematopoietic cell transplantation (HCT)

Although HIV care has historically been considered outside of the scope of practice of emergency department (ED) clinicians, the members of the ED team now have the opportunity to play a key role in United States (US) efforts toward “Ending the Epidemic.”

The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles will review the immunology of MS and its application in therapeutic selection. Using case examples, the faculty will address the disease, drug, and patient factors affecting the choice of initial and sequential therapies.

Patients with CKD and anemia experience substantially increased burdens to morbidity and mortality.

Glaucoma is a heterogeneous group of diseases that has become a major cause of irreversible blindness worldwide.